Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-25-097191
Filing Date
2025-04-25
Accepted
2025-04-25 17:28:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d916160ds3a.htm S-3/A 347114
2 GRAPHIC g916160g95i70.jpg GRAPHIC 44127
  Complete submission text file 0001193125-25-097191.txt   407896
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-286550 | Film No.: 25875341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)